Skip to content

DOCTEUR CAUBO

Active Private limited companyfounded 1997active for 28 yearsBoulevard d'Avroy 7, 4000 LiègeKBO/BCE: BE 0462.133.833

Lifetime

20 annual accounts with figures on one time axis, 21 filings since 2005
peak €117,816 (2011)
€76,957▲ 36.0%
lowest -€27,833 (2023)
€37,756▲ 12.2%
peak €352,677 (2006)
€80,832▲ 87.7%
€86,752▲ 199%
peak 0.7 FTE (2015)
-not published
Board1 name since 2015
1 directorCAUBO Brigitte
Documentsfilings and deeds
22-09-202653 days late
2025micro format
Gross margin from €56,605 to €76,957Equity from €43,075 to €80,832Debts from €28,982 to €86,752Investments €78,489

Key points

from the 2025 annual accounts

Equity

€80,832 from €352,677 in 2006

Equity fell by 77% in 19 years.

Turnover

≈ €170,000 estimated

The micro format states no turnover.

Debts

€86,752 ▲ 199%
Financial debts
+51,824
Suppliers
+140
The rest
+5,805

Debts rose by €57,769 in 2025.

Investments

€78,489 3.5 × depreciation
20212022202320242025

Green is investment, beige is depreciation.

Liquidity

2.68 was 1.68 in 2024

Short-term debts rose from €25,772 to €30,837.

Filings

21 annual accounts since 2005
AprilJune31 JulyOctober20052010201520202025

Ten of the last ten came late. The 2019 accounts came latest: 88 days after the end of the period.

Checked score

81
Excellent
Financially stronger than 49% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.7% 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.8%▲ +0.1 percentage points vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025 06-2025: 0.7%▼ -0.1 percentage points vs 05-2025 07-2025: 0.8%▲ +0.1 percentage points vs 06-2025 08-2025: 1.1%▲ +0.3 percentage points vs 07-2025 09-2025: 1.3%▲ +0.2 percentage points vs 08-2025highest value 10-2025: 0.4%▼ -0.9 percentage points vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.3%▼ -0.1 percentage points vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.4%▲ +0.1 percentage points vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.3%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026 08-2026: 0.7%▲ +0.3 percentage points vs 07-2026 09-2026: 0.8%▲ +0.1 percentage points vs 08-2026 10-2026: 0.5%▼ -0.3 percentage points vs 09-2026 11-2026: 0.5%● unchanged vs 10-2026

Financial strength
Strong

73-12equity 48.2% of total assets
45+11short-term debt 18.4% · cash 0.1%
97-3return on assets 22.5%

Score breakdown

raises risk
Liquidity: current ratio 2.68, cash €206
Last filed accounts filed 53 days late; 2 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Founded in 1997
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 39% of them on solvency, 13% on liquidity, 57% on profitability and 88% on growth.

The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 31,368 companies had the same profile as DOCTEUR CAUBO has now. Each dot stands for 79 companies, two years later.

93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of DOCTEUR CAUBO itself: 0.5% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,368 companies, not a prediction for DOCTEUR CAUBO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €6,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.68 (1.68 in 2024), above the usual 1.5. Short-term debt is 18.4% and cash 0.1% of total assets. However, 51.8% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
raises risk · Liquidity: current ratio 2.68, cash €206
NBB · annual accounts
raises risk · Last filed accounts filed 53 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Founded in 1997
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · 2025 accounts filed 53 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-09-2026, 53 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
53 days late
2024
57 days late
2023
27 days late
2022
29 days late
2021
69 days late
2020
27 days late
2019
88 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 50 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 September (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

CB
Director, since 01-02-2024
Board & ownership

Recent changes

Company renamed to Docteur CAUBO Capital decrease of €6,192.01 · New name: Docteur CAUBO · Resignation: CAUBO Brigitte (manager) · General meeting of 16-01-2024 · Gazette deed
Incorporation published on 25-12-1997 · Gazette deed
First establishment Boulevard d'Avroy 7, Liège
All 31 events

Comparable companies

same main activity, similar in size and age
Company
DOCTEUR CAUBO Liège €167,584 €76,957 48.2% -
Dokter Erwin Van Ingelghem Ostend €180,787 €83,632 85.6% -
Bureau Expertises Médicales BOURDOUXHE Marchin €169,364 €89,999 80.2% -
Cabinet Médical du Docteur Courard Dominique Grâce-Hollogne €201,761 €80,775 84.0% -
MEULDERS Saint-Georges-sur-Meuse €177,401 €84,304 95.6% -
DOCTEUR SEVERIN Nathalie Jalhay €152,689 €92,059 70.9% -
Docteur Pierre CRASBORN Liège €127,043 €64,714 55.6% -

These companies have the same main activity as DOCTEUR CAUBO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €127,000 and €202,000, founded between 1997 and 2003.

Official details

Source: KBO
Status
Active since 17-12-1997Normal situation
Registered office
11 active companies are registered at this addressSource: KBO register, as of 7 November 2026.
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.230.110.5684000 Liège, since 10-12-1997
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

€167,584▲ 133%
Filing
Filed on 22-09-2026
Financials

Insights on DOCTEUR CAUBO

DOCTEUR CAUBO files the micro format. That format states no turnover. The gross margin fell from €83,760 in 2006 to €76,957 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOCTEUR CAUBO

What is the company number of DOCTEUR CAUBO?
The company number of DOCTEUR CAUBO is 0462.133.833. The VAT number is the same number with BE in front: BE 0462.133.833.
Where is DOCTEUR CAUBO based?
The registered office is at Boulevard d'Avroy 7, 4000 Liège.Company details
What does DOCTEUR CAUBO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOCTEUR CAUBO?
DOCTEUR CAUBO is a private limited company (BV).
When was DOCTEUR CAUBO founded?
DOCTEUR CAUBO was founded on 17-12-1997.
Is DOCTEUR CAUBO still active?
Yes, DOCTEUR CAUBO is an active enterprise in the KBO register.
What is the turnover of DOCTEUR CAUBO?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €76,957 and 32 comparable companies (NACE 862). It probably lies between €130,000 and €220,000.Financials
Is DOCTEUR CAUBO profitable?
In financial year 2025, DOCTEUR CAUBO made a profit of €37,756.
Where can I find the annual accounts of DOCTEUR CAUBO?
DOCTEUR CAUBO filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOCTEUR CAUBO due?
DOCTEUR CAUBO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.